Skip to main content
Accretion Nutraveda Limited logo

Accretion Nutraveda Limited — Investor Relations & Filings

Ticker · 544694 ISIN · INE1KVQ01019 LEI · 64882T1HGE34499JZV64 BSE.NS Manufacturing
Open in API
Filings indexed 20 across all filing types
Latest filing 2026-05-15 Earnings Release
Country IN India
Listing BSE.NS 544694

About Accretion Nutraveda Limited

https://accretionnutraveda.com

Accretion Nutraveda Limited is an enterprise focused on the development, manufacturing, and distribution of pharmaceutical, nutraceutical, and Ayurvedic products. The company specializes in integrating traditional herbal wisdom with modern scientific research to produce a diverse range of health and wellness solutions. Its portfolio includes dietary supplements, herbal formulations, vitamins, and personal care items designed to address various therapeutic areas and promote preventive healthcare. By leveraging advanced processing techniques, the firm aims to deliver high-quality, standardized products to healthcare professionals and retail consumers. Core operations emphasize research-driven product development and the expansion of wellness-oriented solutions, focusing on the synergy between natural ingredients and contemporary nutritional science.

Recent filings

Filing Released Lang Actions
Accretion Nutraveda Limited has informed the Exchange regarding Press Release dated 15th May, 2026, titled "Company Delivers Robust Performance in H2 FY26 : Revenue up 80.09% YOY and EBITDA ....
Earnings Release Classification · 91% confidence The document is a media release under SEBI LODR Regulation 30 announcing the company’s audited financial results for the year ended 31 March 2026. It provides key financial highlights (revenue, EBITDA, PAT) and management commentary in a press release format. There are no full financial statements, so it is an initial earnings announcement, matching the Earnings Release category. FY 2026
2026-05-15 English
Please find enclosed herewith Intimation with respect to Appointment Internal Auditor of the company.
Board/Management Information Classification · 91% confidence The document is a stock‐exchange filing under SEBI Listing Regulations announcing the outcome of a Board meeting, including the approval of audited financial results, the reappointment of auditors, the resignation of independent directors, and the appointment of new independent directors. It is not the full financial report itself but a corporate governance disclosure of board and senior management changes. This matches the definition of a Board/Management Information filing (MANG).
2026-05-08 English
Please find enclosed herewith intimation with respect to Appointment of Secretarial Auditor of the Company.
Board/Management Information Classification · 91% confidence The document is an official notice of the outcome of the Board Meeting filed under SEBI Listing Regulations, detailing the approval of audited financial results and multiple changes in board composition (resignation of independent directors and appointment of new independent directors) as well as auditor appointments. This clearly falls under announcements of changes in the company's board of directors and senior management, matching the MANG category.
2026-05-08 English
Please find enclosed herewith Appointment of Ms. Grishma A Shewale as an Additional Non - Executive Independent Director of the Company.
Board/Management Information Classification · 87% confidence The document is titled “Outcome of the Board Meeting dated 08th May, 2026” and is filed under SEBI Listing Regulations, Regulation 30. It details board decisions including the approval of audited financial results, re-appointment of statutory and secretarial auditors, appointment of an internal auditor, and multiple director resignations and appointments. This is clearly a Board/Management announcement regarding changes in the board and senior management, not the full annual report or other filings. Therefore, it should be classified as Board/Management Information (MANG).
2026-05-08 English
Please find enclosed herewith Appointment of Mr. Chand Rameshbhai Kanabar as an Additional Non- Executive Independent Director of the Company.
Board/Management Information Classification · 92% confidence The document is a formal disclosure under Regulation 30 of the SEBI Listing Regulations summarizing the outcome of a Board Meeting, including approval of audited financial results and multiple board and auditor appointments/resignations. It is not the full annual report itself, but an announcement of board management decisions and director changes. This matches the “Board/Management Information” category.
2026-05-08 English
Please find enclosed herewith resignation of Mr. Mahipal singh chouhan as non-Executive Independent Director of the Company.
Board/Management Information Classification · 80% confidence The document is a formal disclosure to the stock exchange under SEBI Listing Regulations detailing the outcome of the Board meeting, which includes approval of audited financial results and, more prominently, multiple changes in Board composition (resignations and appointments of independent directors and auditors). It is not the full annual report or audit report itself but an announcement of Board/management actions. Hence it fits the Board/Management Information category.
2026-05-08 English

Browse filings by year

1 year

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.